BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smith BW, Adams LA. Non-alcoholic fatty liver disease. Crit Rev Clin Lab Sci. 2011;48:97-113. [PMID: 21875310 DOI: 10.3109/10408363.2011.596521] [Cited by in Crossref: 183] [Cited by in F6Publishing: 171] [Article Influence: 16.6] [Reference Citation Analysis]
Number Citing Articles
1 Takaki A, Kawano S, Uchida D, Takahara M, Hiraoka S, Okada H. Paradoxical Roles of Oxidative Stress Response in the Digestive System before and after Carcinogenesis. Cancers (Basel) 2019;11:E213. [PMID: 30781816 DOI: 10.3390/cancers11020213] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
2 Xing YF, Zhang Z, Fu WJ, Zhou DQ, Yuen AC, Mok DK, Chan CO, Tong GD. Shugan Xiaozhi Decoction Attenuates Nonalcoholic Steatohepatitis by Enhancing PPARα and L-FABP Expressions in High-Fat-Fed Rats. Evid Based Complement Alternat Med 2016;2016:7870189. [PMID: 28003852 DOI: 10.1155/2016/7870189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Shim P, Choi D, Park Y. Association of Blood Fatty Acid Composition and Dietary Pattern with the Risk of Non-Alcoholic Fatty Liver Disease in Patients Who Underwent Cholecystectomy. Ann Nutr Metab 2017;70:303-11. [PMID: 28595185 DOI: 10.1159/000475605] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
4 Kalaki-jouybari F, Shanaki M, Delfan M, Gorgani-firouzjae S, Khakdan S. High-intensity interval training (HIIT) alleviated NAFLD feature via miR-122 induction in liver of high-fat high-fructose diet induced diabetic rats. Archives of Physiology and Biochemistry 2020;126:242-9. [DOI: 10.1080/13813455.2018.1510968] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Ergelen R, Akyuz U, Aydin Y, Eren F, Yilmaz Y. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2015;27:667-71. [DOI: 10.1097/meg.0000000000000342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
6 Yao J, Zhi M, Gao X, Hu P, Li C, Yang X. Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver. Braz J Med Biol Res 2013;46:270-7. [PMID: 23532271 DOI: 10.1590/1414-431x20122551] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
7 Devasani K, Kaul R, Majumdar A. Supplementation of pyrroloquinoline quinone with atorvastatin augments mitochondrial biogenesis and attenuates low grade inflammation in obese rats. Eur J Pharmacol 2020;881:173273. [PMID: 32535101 DOI: 10.1016/j.ejphar.2020.173273] [Reference Citation Analysis]
8 Yang GL, Jia LQ, Wu J, Ma YX, Cao HM, Song N, Zhang N. Effect of tanshinone IIA on oxidative stress and apoptosis in a rat model of fatty liver. Exp Ther Med 2017;14:4639-46. [PMID: 29201162 DOI: 10.3892/etm.2017.5162] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
9 Doskey CM, Fader KA, Nault R, Lydic T, Matthews J, Potter D, Sharratt B, Williams K, Zacharewski T. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters hepatic polyunsaturated fatty acid metabolism and eicosanoid biosynthesis in female Sprague-Dawley rats. Toxicol Appl Pharmacol 2020;398:115034. [PMID: 32387183 DOI: 10.1016/j.taap.2020.115034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li G, Zhou F, Chen Y, Zhang W, Wang N. Kukoamine A attenuates insulin resistance and fatty liver through downregulation of Srebp-1c. Biomed Pharmacother. 2017;89:536-543. [PMID: 28254666 DOI: 10.1016/j.biopha.2017.02.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
11 Zhang H, Shen WJ, Cortez Y, Kraemer FB, Azhar S. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways. Am J Physiol Gastrointest Liver Physiol 2013;304:G72-86. [PMID: 23104557 DOI: 10.1152/ajpgi.00328.2012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
12 Wang S, Lei T, Zhou L, Zheng H, Zeng C, Liu N, Yang Z, Chen X. Functional analysis and transcriptional regulation of porcine six transmembrane epithelial antigen of prostate 4 (STEAP4) gene and its novel variant in hepatocytes. The International Journal of Biochemistry & Cell Biology 2013;45:612-20. [DOI: 10.1016/j.biocel.2012.12.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
13 Irie M, Sohda T, Anan A, Fukunaga A, Takata K, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Shakado S, Sakisaka S. Reduced Glutathione suppresses Oxidative Stress in Nonalcoholic Fatty Liver Disease. Euroasian J Hepatogastroenterol 2016;6:13-8. [PMID: 29201718 DOI: 10.5005/jp-journals-10018-1159] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
14 Rajas F, Gautier-Stein A, Mithieux G. Glucose-6 Phosphate, A Central Hub for Liver Carbohydrate Metabolism. Metabolites 2019;9:E282. [PMID: 31756997 DOI: 10.3390/metabo9120282] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
15 Koliaki C, Roden M. Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. Mol Cell Endocrinol. 2013;379:35-42. [PMID: 23770462 DOI: 10.1016/j.mce.2013.06.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
16 Ke Z, Zhao Z, Zhao Y, Xu X, Li Y, Tan S, Huang C, Zhou Z. PMFs-rich Citrus extract prevents the development of non-alcoholic fatty liver disease in C57BL/6J mice induced by a high-fat diet. Journal of Functional Foods 2018;47:28-39. [DOI: 10.1016/j.jff.2018.05.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
17 Hartler J, Köfeler HC, Trötzmüller M, Thallinger GG, Spener F. Assessment of lipidomic species in hepatocyte lipid droplets from stressed mouse models. Sci Data 2014;1:140051. [PMID: 25977802 DOI: 10.1038/sdata.2014.51] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
18 Deng Z, Gao S, An Y, Huang Y, Liu H, Zhu W, Lu W, He M, Xie W, Yu D, Li Y. Effects of earthworm extract on the lipid profile and fatty liver induced by a high-fat diet in guinea pigs. Ann Transl Med 2021;9:292. [PMID: 33708919 DOI: 10.21037/atm-20-5362] [Reference Citation Analysis]
19 Kamisako T, Tanaka Y, Kishino Y, Ikeda T, Yamamoto K, Masuda S, Ogawa H. Role of Nrf2 in the alteration of cholesterol and bile acid metabolism-related gene expression by dietary cholesterol in high fat-fed mice. J Clin Biochem Nutr 2014;54:90-4. [PMID: 24688217 DOI: 10.3164/jcbn.13-92] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
20 Mohan H, Brandt SL, Kim JH, Wong F, Lai M, Prentice KJ, Al Rijjal D, Magomedova L, Batchuluun B, Burdett E, Bhattacharjee A, Cummins CL, Belsham DD, Cox B, Liu Y, Wheeler MB. 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) prevents high fat diet-induced insulin resistance via maintenance of hepatic lipid homeostasis. Diabetes Obes Metab 2019;21:61-72. [PMID: 30062833 DOI: 10.1111/dom.13483] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
21 Agostinis-sobrinho C, Vicente SEDCF, Kievišienė J, Lopes L, Dâmaso AR, Norkiene S, Rosário R, Campos RMDS, Ramirez-velez R, Mota J, Santos R. High levels of adiponectin attenuate the detrimental association of adiposity with insulin resistance in adolescents. Nutrition, Metabolism and Cardiovascular Diseases 2020;30:822-8. [DOI: 10.1016/j.numecd.2020.02.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Xue H, Chen D, Zhong Y, Zhou Z, Fang S, Li M, Guo C. Deferoxamine ameliorates hepatosteatosis via several mechanisms in ob/ob mice. Ann N Y Acad Sci 2016;1375:52-65. [DOI: 10.1111/nyas.13174] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
23 Li T, Geng L, Chen X, Miskowiec M, Li X, Dong B. Branched-chain amino acids alleviate nonalcoholic steatohepatitis in rats. Appl Physiol Nutr Metab. 2013;38:836-843. [PMID: 23855271 DOI: 10.1139/apnm-2012-0496] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
24 Anisonyan AV, Sandler YG, Khaimenova TY, Keyan VA, Saliev KG, Sbikina ES, Vinnitskaya EV. [Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics]. Ter Arkh 2020;92:73-8. [PMID: 33346465 DOI: 10.26442/00403660.2020.08.000770] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Sihali-Beloui O, Aroune D, Benazouz F, Hadji A, El-Aoufi S, Marco S. A hypercaloric diet induces hepatic oxidative stress, infiltration of lymphocytes, and mitochondrial reshuffle in Psammomys obesus, a murine model of insulin resistance. C R Biol 2019;342:209-19. [PMID: 31151779 DOI: 10.1016/j.crvi.2019.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
26 Caballería L, Arteaga I, Pera G, Rodríguez L, Alumà A, Auladell MA, Torán P. [Risk factors associated with non-alcoholic fatty liver disease: a case-control study]. Med Clin (Barc) 2013;141:233-9. [PMID: 23601740 DOI: 10.1016/j.medcli.2012.11.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
27 Kim HM, Kim Y, Lee ES, Huh JH, Chung CH. Caffeic acid ameliorates hepatic steatosis and reduces ER stress in high fat diet-induced obese mice by regulating autophagy. Nutrition. 2018;55-56:63-70. [PMID: 29960159 DOI: 10.1016/j.nut.2018.03.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
28 Cheng Y, Hou T, Ping J, Chen G, Chen J. Quantitative succinylome analysis in the liver of non-alcoholic fatty liver disease rat model. Proteome Sci 2016;14:3. [PMID: 26843850 DOI: 10.1186/s12953-016-0092-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
29 Suzuki M, Takeda M, Kito A, Fukazawa M, Yata T, Yamamoto M, Nagata T, Fukuzawa T, Yamane M, Honda K. Tofogliflozin, a sodium/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models. Nutr Diabetes. 2014;4:e125. [PMID: 25000147 DOI: 10.1038/nutd.2014.20] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 7.8] [Reference Citation Analysis]
30 Roberts NT, Hernando D, Holmes JH, Wiens CN, Reeder SB. Noise properties of proton density fat fraction estimated using chemical shift-encoded MRI. Magn Reson Med 2018;80:685-95. [PMID: 29322549 DOI: 10.1002/mrm.27065] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
31 Heritage M, Jaskowski L, Bridle K, Campbell C, Briskey D, Britton L, Fletcher L, Vitetta L, Subramaniam VN, Crawford D. Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice. World J Gastrointest Pathophysiol 2017; 8(2): 67-76 [PMID: 28573069 DOI: 10.4291/wjgp.v8.i2.67] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
32 Yang MH, Sung J, Gwak G. The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population. Journal of Clinical Lipidology 2016;10:289-98. [DOI: 10.1016/j.jacl.2015.11.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
33 Yilmaz Y, Eren F, Colak Y, Senates E, Celikel CA, Imeryuz N. Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease. Scand J Gastroenterol 2012;47:1488-93. [PMID: 23137022 DOI: 10.3109/00365521.2012.725093] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
34 Zhang Z, Dai Y, Wang H, Wang M. Supplementation of the maternal diet during pregnancy with chocolate and fructose interacts with the high-fat diet of the young to facilitate the onset of metabolic disorders in rat offspring. Clin Exp Pharmacol Physiol 2013;40:652-61. [DOI: 10.1111/1440-1681.12147] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
35 Wang K, Cao P, Wang H, Tang Z, Wang N, Wang J, Zhang Y. Chronic administration of Angelica sinensis polysaccharide effectively improves fatty liver and glucose homeostasis in high-fat diet-fed mice. Sci Rep 2016;6:26229. [PMID: 27189109 DOI: 10.1038/srep26229] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
36 Park M, Jang H, Lee J, Lee Y, Kim J, Park J, Park D. Effect of Hog Millet Supplementation on Hepatic Steatosis and Insulin Resistance in Mice Fed a High-fat Diet. Journal of the Korean Society of Food Science and Nutrition 2012;41:501-9. [DOI: 10.3746/jkfn.2012.41.4.501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
37 Uchida D, Takaki A, Adachi T, Okada H. Beneficial and Paradoxical Roles of Anti-Oxidative Nutritional Support for Non-Alcoholic Fatty Liver Disease. Nutrients 2018;10:E977. [PMID: 30060482 DOI: 10.3390/nu10080977] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
38 Dhruva V, Lawson C, Green C, Newberry C. "The Gluten-Free Diet and Its Relationship with Metabolic Syndrome: Dietary Friend or Foe?". Curr Nutr Rep 2021. [PMID: 34510390 DOI: 10.1007/s13668-021-00371-3] [Reference Citation Analysis]
39 de Jonge C, Rensen SS, Koek GH, Joosten MF, Buurman WA, Bouvy ND, Greve JW. Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2013;11:1517-20. [PMID: 23920034 DOI: 10.1016/j.cgh.2013.07.029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
40 Terra X, Auguet T, Broch M, Sabench F, Hernández M, Pastor RM, Quesada IM, Luna A, Aguilar C, del Castillo D. Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women. Obesity (Silver Spring). 2013;21:170-177. [PMID: 23505183 DOI: 10.1002/oby.20233] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
41 Domenici FA, Brochado MJ, Martinelli Ade L, Zucoloto S, da Cunha SF, Vannucchi H. Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients. Gene. 2013;529:326-331. [PMID: 23891824 DOI: 10.1016/j.gene.2013.06.091] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
42 Spahis S, Alvarez F, Dubois J, Ahmed N, Peretti N, Levy E. Plasma fatty acid composition in French-Canadian children with non-alcoholic fatty liver disease: Effect of n-3 PUFA supplementation. Prostaglandins Leukot Essent Fatty Acids. 2015;99:25-34. [PMID: 26066299 DOI: 10.1016/j.plefa.2015.04.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
43 Marino JS, Stechschulte LA, Stec DE, Nestor-Kalinoski A, Coleman S, Hinds TD Jr. Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α. J Biol Chem 2016;291:25776-88. [PMID: 27784782 DOI: 10.1074/jbc.M116.752311] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
44 Takahashi Y. The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver. Int J Mol Sci. 2017;18. [PMID: 28678199 DOI: 10.3390/ijms18071447] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 14.8] [Reference Citation Analysis]
45 Kelley NS. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans. Metabolic Syndrome and Related Disorders 2016;14:417-30. [DOI: 10.1089/met.2016.0051] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
46 Huiqing L, Jiaen Y, Jinmo T, Chuncheng W, Hongshan L, Shaodong C. Optimization of dosage ratio of chlorogenic acid and gardenia glycosides in the treatment of rats with fatty liver disease induced by high-fat feed. Journal of Traditional Chinese Medicine 2016;36:683-8. [DOI: 10.1016/s0254-6272(16)30090-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
47 Upala S, Jaruvongvanich V, Wijarnpreecha K, Sanguankeo A. Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis. J Bone Miner Metab 2017;35:685-93. [DOI: 10.1007/s00774-016-0807-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
48 Song KH, Lee MY, Yoo CH, Lim SI, Choe BY. Improved quantitative fatty acid values with correction of T2 relaxation time in terminal methyl group: In vivo proton magnetic resonance spectroscopy at ultra high field in hepatic steatosis. Chem Phys Lipids 2018;212:35-43. [PMID: 29337015 DOI: 10.1016/j.chemphyslip.2018.01.004] [Reference Citation Analysis]
49 Wang Y, Hong J, Shi M, Guo L, Liu L, Tang H, Liu X. Triphenyl phosphate disturbs the lipidome and induces endoplasmic reticulum stress and apoptosis in JEG-3 cells. Chemosphere 2021;275:129978. [PMID: 33662732 DOI: 10.1016/j.chemosphere.2021.129978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Firneisz G. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: The liver disease of our age? World J Gastroenterol 2014; 20(27): 9072-9089 [PMID: 25083080 DOI: 10.3748/wjg.v20.i27.9072] [Cited by in F6Publishing: 47] [Reference Citation Analysis]
51 Holzberg JR, Jin R, Le NA, Ziegler TR, Brunt EM, McClain CJ, Konomi JV, Arteel GE, Vos MB. Plasminogen Activator Inhibitor-1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight. J Pediatr Gastroenterol Nutr 2016;62:819-23. [PMID: 26704864 DOI: 10.1097/MPG.0000000000001096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
52 Liu Y, Shi D, Liu Y, Zhao Y, Tian Y, Xu J, Wang J, Xue C. Eicosapentaenoic acid-containing phosphatidylcholine alleviated lipid accumulation in orotic acid-induced non-alcoholic fatty liver. Journal of Functional Foods 2016;23:294-305. [DOI: 10.1016/j.jff.2016.02.041] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
53 MacLean C, Dillon J, Babraj JA, Vollaard NB. The effect of low volume sprint interval training in patients with non-alcoholic fatty liver disease. Phys Sportsmed 2018;46:87-92. [PMID: 29183220 DOI: 10.1080/00913847.2018.1411171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
54 Nakajima K. Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease. Int J Hepatol 2012;2012:950693. [PMID: 23304532 DOI: 10.1155/2012/950693] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
55 Ji L, Li CP. Role of ChREBP and its target gene PNPLA3 in pathogenesis of nonalcoholic fatty liver disease in rats. Shijie Huaren Xiaohua Zazhi 2014; 22(19): 2679-2685 [DOI: 10.11569/wcjd.v22.i19.2679] [Reference Citation Analysis]
56 Abernathy BE, Schoenfuss TC, Bailey AS, Gallaher DD. Polylactose Exhibits Prebiotic Activity and Reduces Adiposity and Nonalcoholic Fatty Liver Disease in Rats Fed a High-Fat Diet. J Nutr 2021;151:352-60. [PMID: 33382431 DOI: 10.1093/jn/nxaa376] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Qiu LX, Chen T. Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease. World J Gastroenterol 2015; 21(4): 1099-1107 [PMID: 25632182 DOI: 10.3748/wjg.v21.i4.1099] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
58 Gasim GI, Elshehri FM, Kheidr M, Alshubaily FK, ElZaki EM, Musa IR. The Use of Computed Tomography in the Diagnosis of Fatty Liver and Abdominal Fat Distribution among a Saudi Population. Open Access Maced J Med Sci 2017;5:762-5. [PMID: 29104685 DOI: 10.3889/oamjms.2017.187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
59 Yilmaz Y. Serum proteomics for biomarker discovery in nonalcoholic fatty liver disease. Clin Chim Acta. 2012;413:1190-1193. [PMID: 22546610 DOI: 10.1016/j.cca.2012.04.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
60 Doycheva I, Patel N, Peterson M, Loomba R. Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. J Diabetes Complications. 2013;27:293-300. [PMID: 23312215 DOI: 10.1016/j.jdiacomp.2012.10.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
61 Bruni V, Peruzzi E, Dei M, Nannini S, Seravalli V, Sisti G, Fambrini M. Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females. Fertility and Sterility 2012;98:1047-52. [DOI: 10.1016/j.fertnstert.2012.06.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
62 Nishizawa H, Takahashi M, Fukuoka H, Iguchi G, Kitazawa R, Takahashi Y. GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model. Biochem Biophys Res Commun. 2012;423:295-300. [PMID: 22659415 DOI: 10.1016/j.bbrc.2012.05.115] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
63 Solano-Urrusquieta A, Morales-González JA, Castro-Narro GE, Cerda-Reyes E, Flores-Rangel PD, Fierros-Oceguera R. NRF-2 and nonalcoholic fatty liver disease. Ann Hepatol 2020;19:458-65. [PMID: 31959521 DOI: 10.1016/j.aohep.2019.11.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
64 Quan HY, Kim do Y, Kim SJ, Jo HK, Kim GW, Chung SH. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway. Biochem Pharmacol. 2013;85:1330-1340. [PMID: 23435355 DOI: 10.1016/j.bcp.2013.02.007] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 8.7] [Reference Citation Analysis]
65 Yilmaz Y, Ozturk O, Alahdab YO, Senates E, Colak Y, Doganay HL, Coskunpinar E, Oltulu YM, Eren F, Atug O, Tuncer I, Imeryuz N. Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease. Dig Liver Dis 2013;45:58-62. [PMID: 22995553 DOI: 10.1016/j.dld.2012.08.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
66 Ryu Y, Kim SW, Kim YY, Ku SY. Animal Models for Human Polycystic Ovary Syndrome (PCOS) Focused on the Use of Indirect Hormonal Perturbations: A Review of the Literature. Int J Mol Sci 2019;20:E2720. [PMID: 31163591 DOI: 10.3390/ijms20112720] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
67 Hung MC, Chen CF, Tsou MT, Lin HH, Hwang LC, Hsu CP. Relationship Between Gallstone Disease and Cardiometabolic Risk Factors in Elderly People with Non-Alcoholic Fatty Liver Disease. Diabetes Metab Syndr Obes 2020;13:3579-85. [PMID: 33116709 DOI: 10.2147/DMSO.S266947] [Reference Citation Analysis]
68 Sahini N, Borlak J. Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes. Prog Lipid Res. 2014;54:86-112. [PMID: 24607340 DOI: 10.1016/j.plipres.2014.02.002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 7.9] [Reference Citation Analysis]
69 Cheng S, Wiklund P, Autio R, Borra R, Ojanen X, Xu L, Törmäkangas T, Alen M. Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease. PLoS One 2015;10:e0138889. [PMID: 26439744 DOI: 10.1371/journal.pone.0138889] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
70 Bai J, He Z, Li Y, Jiang X, Yu H, Tan Q. Mono-2-ethylhexyl phthalate induces the expression of genes involved in fatty acid synthesis in HepG2 cells. Environ Toxicol Pharmacol 2019;69:104-11. [PMID: 31004931 DOI: 10.1016/j.etap.2019.04.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
71 Gunn HM, Emilsson H, Gabriel M, Maguire AM, Steinbeck KS. Metabolic Health in Childhood Cancer Survivors: A Longitudinal Study in a Long-Term Follow-Up Clinic. J Adolesc Young Adult Oncol 2016;5:24-30. [PMID: 26812459 DOI: 10.1089/jayao.2015.0036] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
72 Liang C, Li J, Tian B, Tian L, Liu Y, Li J, Xin L, Wang J, Fu C, Shi Z, Xia J, Liang Y, Wang K. Foresight regarding drug candidates acting on the succinate-GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment. Biomed Pharmacother 2021;144:112298. [PMID: 34649219 DOI: 10.1016/j.biopha.2021.112298] [Reference Citation Analysis]
73 . Lipids, Atherogenic Dyslipidemia, and Therapy. Metabolic Syndrome and Cardiovascular Disease. Oxford: Blackwell Publishing Ltd.; 2012. pp. 347-408. [DOI: 10.1002/9781118480045.ch13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
74 Liu M, Xu L, Yin L, Qi Y, Xu Y, Han X, Zhao Y, Sun H, Yao J, Lin Y. Potent effects of dioscin against obesity in mice. Sci Rep. 2015;5:7973. [PMID: 25609476 DOI: 10.1038/srep07973] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
75 Chaves Cayuela N, Kiyomi Koike M, Jacysyn JF, Rasslan R, Azevedo Cerqueira AR, Pereira Costa SK, Picanço Diniz-Júnior JA, Massazo Utiyama E, Frasson de Souza Montero E. N-Acetylcysteine Reduced Ischemia and Reperfusion Damage Associated with Steatohepatitis in Mice. Int J Mol Sci 2020;21:E4106. [PMID: 32526845 DOI: 10.3390/ijms21114106] [Reference Citation Analysis]
76 Fleury N, Geldenhuys S, Gorman S. Sun Exposure and Its Effects on Human Health: Mechanisms through Which Sun Exposure Could Reduce the Risk of Developing Obesity and Cardiometabolic Dysfunction. Int J Environ Res Public Health 2016;13:E999. [PMID: 27727191 DOI: 10.3390/ijerph13100999] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
77 Wang BF, Wang Y, Ao R, Tong J, Wang BY. AdipoQ T45 G and G276 T Polymorphisms and Susceptibility to Nonalcoholic Fatty Liver Disease Among Asian Populations: A Meta-Analysis and Meta-Regression. J Clin Lab Anal 2016;30:47-57. [PMID: 25385252 DOI: 10.1002/jcla.21814] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
78 Heeks LV, Hooper AJ, Adams LA, Robbins P, Barrett PHR, van Bockxmeer FM, Burnett JR. Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia. Clinica Chimica Acta 2013;421:121-5. [DOI: 10.1016/j.cca.2013.03.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
79 Wang Q, Ou Y, Hu G, Wen C, Yue S, Chen C, Xu L, Xie J, Dai H, Xiao H, Zhang Y, Qi R. Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-κB pathway in mice. Br J Pharmacol 2020;177:1806-21. [PMID: 31758699 DOI: 10.1111/bph.14938] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
80 Barbosa-da-Silva S, da Silva NC, Aguila MB, Mandarim-de-Lacerda CA. Liver damage is not reversed during the lean period in diet-induced weight cycling in mice. Hepatol Res 2014;44:450-9. [PMID: 23607320 DOI: 10.1111/hepr.12138] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
81 Michopoulos S, Chouzouri VI, Manios ED, Grapsa E, Antoniou Z, Papadimitriou CA, Zakopoulos N, Dimopoulos AM. Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center. Clin Exp Gastroenterol 2016;9:1-9. [PMID: 26834493 DOI: 10.2147/CEG.S92714] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
82 Song Y, Wu W, Sheng L, Jiang B, Li X, Cai K. Chrysin ameliorates hepatic steatosis induced by a diet deficient in methionine and choline by inducing the secretion of hepatocyte nuclear factor 4α-dependent very low-density lipoprotein. J Biochem Mol Toxicol 2020;34:e22497. [PMID: 32220030 DOI: 10.1002/jbt.22497] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
83 Li Y, Lu Z, Ru JH, Lopes-Virella MF, Lyons TJ, Huang Y. Saturated fatty acid combined with lipopolysaccharide stimulates a strong inflammatory response in hepatocytes in vivo and in vitro. Am J Physiol Endocrinol Metab 2018;315:E745-57. [PMID: 29989851 DOI: 10.1152/ajpendo.00015.2018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
84 Hua MC, Su HM, Yao TC, Kuo ML, Lai MW, Tsai MH, Huang JL. Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis. PLoS One 2017;12:e0182277. [PMID: 28759573 DOI: 10.1371/journal.pone.0182277] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
85 El Khoury D, Pauley RJ, Berseth CL. Dietary approaches to managing nonalcoholic fatty liver disease. Nurse Pract 2021;46:19-26. [PMID: 33399334 DOI: 10.1097/01.NPR.0000731560.23509.ff] [Reference Citation Analysis]
86 Qiao QH, Zhu WH, Yu YX, Huang FF, Chen LY. Nonalcoholic fatty liver was associated with asymptomatic gallstones in a Chinese population. Medicine (Baltimore) 2017;96:e7853. [PMID: 28930823 DOI: 10.1097/MD.0000000000007853] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
87 Guo Y, Han X, Che H, Li Z, Dong P, Xue C, Zhang T, Wang Y. Synergistic effect of eicosapentaenoic acid-enriched phospholipids and sea cucumber saponin on orotic acid-induced non-alcoholic fatty liver disease in rats. R Soc Open Sci 2018;5:172182. [PMID: 30109054 DOI: 10.1098/rsos.172182] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
88 Lu Y, Jiang Z, Dai H, Miao R, Shu J, Gu H, Liu X, Huang Z, Yang G, Chen AF, Yuan H, Li Y, Cai J. Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway. Hepatology 2018;67:1303-19. [PMID: 29091299 DOI: 10.1002/hep.29633] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
89 Zeng T, Zhang CL, Zhao XL, Xie KQ. Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies. Eur J Gastroenterol Hepatol. 2014;26:646-653. [PMID: 24743504 DOI: 10.1097/meg.0000000000000068] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
90 Kwon C, Sun JL, Jeong JH, Jung TW. Humanin attenuates palmitate-induced hepatic lipid accumulation and insulin resistance via AMPK-mediated suppression of the mTOR pathway. Biochemical and Biophysical Research Communications 2020;526:539-45. [DOI: 10.1016/j.bbrc.2020.03.128] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
91 Shpyleva S, Pogribna M, Cozart C, Bryant MS, Muskhelishvili L, Tryndyak VP, Ross SA, Beland FA, Pogribny IP. Interstrain differences in the progression of nonalcoholic steatohepatitis to fibrosis in mice are associated with altered hepatic iron metabolism. J Nutr Biochem. 2014;25:1235-1242. [PMID: 25256357 DOI: 10.1016/j.jnutbio.2014.06.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
92 Aykut UE, Akyuz U, Yesil A, Eren F, Gerin F, Ergelen R, Celikel CA, Yilmaz Y. A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. Scand J Gastroenterol 2014;49:1343-8. [PMID: 25259621 DOI: 10.3109/00365521.2014.958099] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
93 Zhou X, Han D, Xu R, Wu H, Qu C, Wang F, Wang X, Zhao Y. Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats. Oncotarget 2016;7:80223-37. [PMID: 27784003 DOI: 10.18632/oncotarget.12831] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
94 Silva RN, Bueno PG, Avó LR, Nonaka KO, Selistre-Araújo HS, Leal AM. Effect of physical training on liver expression of activin A and follistatin in a nonalcoholic fatty liver disease model in rats. Braz J Med Biol Res 2014;47:746-52. [PMID: 25075578 DOI: 10.1590/1414-431x20143869] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
95 Zhang S, Zheng L, Dong D, Xu L, Yin L, Qi Y, Han X, Lin Y, Liu K, Peng J. Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats. Food Chem. 2013;141:2108-2116. [PMID: 23870935 DOI: 10.1016/j.foodchem.2013.05.019] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 7.3] [Reference Citation Analysis]
96 Xie Y, Zhang Y, Guo Z, Zeng H, Zheng B. Effect of Alkaloids from Nelumbinis Plumula against Insulin Resistance of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. J Diabetes Res 2016;2016:3965864. [PMID: 27761469 DOI: 10.1155/2016/3965864] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
97 Fjære E, Andersen C, Myrmel LS, Petersen RK, Hansen JB, Tastesen HS, Mandrup-Poulsen T, Brünner N, Kristiansen K, Madsen L, Rømer MU. Tissue Inhibitor Of Matrix Metalloproteinase-1 Is Required for High-Fat Diet-Induced Glucose Intolerance and Hepatic Steatosis in Mice. PLoS One 2015;10:e0132910. [PMID: 26168159 DOI: 10.1371/journal.pone.0132910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
98 Fukunaga K, Imachi H, Lyu J, Dong T, Sato S, Ibata T, Kobayashi T, Yoshimoto T, Yonezaki K, Matsunaga T, Murao K. IGF1 suppresses cholesterol accumulation in the liver of growth hormone-deficient mice via the activation of ABCA1. American Journal of Physiology-Endocrinology and Metabolism 2018;315:E1232-41. [DOI: 10.1152/ajpendo.00134.2018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
99 Kanwar P, Nelson JE, Yates K, Kleiner DE, Unalp-Arida A, Kowdley KV. Association between metabolic syndrome and liver histology among NAFLD patients without diabetes. BMJ Open Gastroenterol 2016;3:e000114. [PMID: 27933201 DOI: 10.1136/bmjgast-2016-000114] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
100 Sharma A, Anand SK, Singh N, Dwarkanath A, Dwivedi UN, Kakkar P. Berbamine induced activation of the SIRT1/LKB1/AMPK signaling axis attenuates the development of hepatic steatosis in high-fat diet-induced NAFLD rats. Food Funct 2021;12:892-909. [PMID: 33411880 DOI: 10.1039/d0fo02501a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
101 Khodarahmi A, Eshaghian A, Safari F, Moradi A. Quercetin Mitigates Hepatic Insulin Resistance in Rats with Bile Duct Ligation Through Modulation of the STAT3/SOCS3/IRS1 Signaling Pathway. Journal of Food Science 2019;84:3045-53. [DOI: 10.1111/1750-3841.14793] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
102 Lee YC, Wu JS, Yang YC, Chang CS, Lu FH, Chang CJ. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease. Scand J Gastroenterol 2014;49:1001-6. [PMID: 24989169 DOI: 10.3109/00365521.2014.920912] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
103 Gordon DM, Adeosun SO, Ngwudike SI, Anderson CD, Hall JE, Hinds TD Jr, Stec DE. CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation. Arch Biochem Biophys 2019;672:108072. [PMID: 31422074 DOI: 10.1016/j.abb.2019.108072] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
104 Kontana A, Tziomalos K. Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease. World J Gastroenterol 2019; 25(28): 3664-3668 [PMID: 31391764 DOI: 10.3748/wjg.v25.i28.3664] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
105 He Q, Li JK, Li F, Li RG, Zhan GQ, Li G, Du WX, Tan HB. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats. World J Gastroenterol 2015; 21(7): 2058-2066 [PMID: 25717238 DOI: 10.3748/wjg.v21.i7.2058] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
106 Chen X, Acquaah-Mensah GK, Denning KL, Peterson JM, Wang K, Denvir J, Hong F, Cederbaum AI, Lu Y. High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARα: a new model for steatohepatitis-associated fibrosis. Am J Physiol Gastrointest Liver Physiol 2020;319:G626-35. [PMID: 32877213 DOI: 10.1152/ajpgi.00213.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
107 Tang W, Jiang YF, Ponnusamy M, Diallo M. Role of Nrf2 in chronic liver disease. World J Gastroenterol 2014; 20(36): 13079-13087 [PMID: 25278702 DOI: 10.3748/wjg.v20.i36.13079] [Cited by in CrossRef: 111] [Cited by in F6Publishing: 100] [Article Influence: 13.9] [Reference Citation Analysis]
108 Shang W, Li H, Strappe P, Zhou Z, Blanchard C. Konjac glucomannans attenuate diet-induced fat accumulation on livers and its regulation pathway. Journal of Functional Foods 2019;52:258-65. [DOI: 10.1016/j.jff.2018.11.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
109 Wang Y, Song J, Bian H, Bo J, Lv S, Pan W, Lv X. Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells. Mol Cell Biochem. 2019;460:205-215. [PMID: 31270645 DOI: 10.1007/s11010-019-03581-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
110 Zeraattalab-Motlagh S, Jayedi A, Shab-Bidar S. The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials. Am J Clin Nutr 2021:nqab250. [PMID: 34320173 DOI: 10.1093/ajcn/nqab250] [Reference Citation Analysis]
111 Kruse M, von Loeffelholz C, Hoffmann D, Pohlmann A, Seltmann AC, Osterhoff M, Hornemann S, Pivovarova O, Rohn S, Jahreis G, Pfeiffer AF. Dietary rapeseed/canola-oil supplementation reduces serum lipids and liver enzymes and alters postprandial inflammatory responses in adipose tissue compared to olive-oil supplementation in obese men. Mol Nutr Food Res 2015;59:507-19. [PMID: 25403327 DOI: 10.1002/mnfr.201400446] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
112 Aliasghari F, Izadi A, Gargari BP, Ebrahimi S. The Effects of Ramadan Fasting on Body Composition, Blood Pressure, Glucose Metabolism, and Markers of Inflammation in NAFLD Patients: An Observational Trial. J Am Coll Nutr 2017;36:640-5. [PMID: 28922096 DOI: 10.1080/07315724.2017.1339644] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
113 Gong L, Li G, Zhang W, Liu H, Lv Y, Han F, Wan Z, Shi M, Liu L. Akebia Saponin D Decreases Hepatic Steatosis through Autophagy Modulation. J Pharmacol Exp Ther 2016;359:392-400. [DOI: 10.1124/jpet.116.236562] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
114 Trovato FM, Catalano D, Musumeci G, Trovato GM. 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics. EPMA J. 2014;5:21. [PMID: 25937854 DOI: 10.1186/1878-5085-5-21] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
115 Cheng Y, Zhang K, Chen Y, Li Y, Li Y, Fu K, Feng R. Associations between Dietary Nutrient Intakes and Hepatic Lipid Contents in NAFLD Patients Quantified by ¹H-MRS and Dual-Echo MRI. Nutrients 2016;8:E527. [PMID: 27618908 DOI: 10.3390/nu8090527] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
116 Nakajima K, Oshida H, Muneyuki T, Saito M, Hori Y, Fuchigami H, Kakei M, Munakata H. Independent association between low serum amylase and non-alcoholic fatty liver disease in asymptomatic adults: a cross-sectional observational study. BMJ Open 2013;3:e002235. [PMID: 23293250 DOI: 10.1136/bmjopen-2012-002235] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
117 Qi S, Wang C, Li C, Wang P, Liu M. Candidate genes investigation for severe nonalcoholic fatty liver disease based on bioinformatics analysis. Medicine (Baltimore) 2017;96:e7743. [PMID: 28796060 DOI: 10.1097/MD.0000000000007743] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
118 Ye P, Cheah IK, Halliwell B. A high-fat and cholesterol diet causes fatty liver in guinea pigs. The role of iron and oxidative damage. Free Radical Research 2013;47:602-13. [DOI: 10.3109/10715762.2013.806796] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
119 Lopes LAR, Martins MDCCE, Farias LM, Brito AKDS, Lima GM, Carvalho VBL, Pereira CFC, Conde Júnior AM, Saldanha T, Arêas JAG, Silva KJDE, Frota KMG. Cholesterol-Lowering and Liver-Protective Effects of Cooked and Germinated Mung Beans (Vigna radiata L.). Nutrients 2018;10:E821. [PMID: 29949855 DOI: 10.3390/nu10070821] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
120 Quan HY, Kim SJ, Kim DY, Jo HK, Kim GW, Chung SH. Licochalcone A regulates hepatic lipid metabolism through activation of AMP-activated protein kinase. Fitoterapia 2013;86:208-16. [PMID: 23500383 DOI: 10.1016/j.fitote.2013.03.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
121 Petyaev IM, Dovgalevsky PY, Chalyk NE, Klochkov VA, Kyle NH, Bashmakov YK. Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary Report. Int J Chronic Dis 2018;2018:4549614. [PMID: 29805971 DOI: 10.1155/2018/4549614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
122 Abdel-Wahab R, Shehata S, Hassan MM, Habra MA, Eskandari G, Tinkey PT, Mitchell J, Lee JS, Amin HM, Kaseb AO. Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma. J Hepatocell Carcinoma 2015;2:131-42. [PMID: 27508202 DOI: 10.2147/JHC.S81309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
123 Zhao L, Cang Z, Sun H, Nie X, Wang N, Lu Y. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease. BMC Endocr Disord 2017;17:13. [PMID: 28241817 DOI: 10.1186/s12902-017-0165-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
124 Nishizawa H, Iguchi G, Fukuoka H, Takahashi M, Suda K, Bando H, Matsumoto R, Yoshida K, Odake Y, Ogawa W, Takahashi Y. IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner. Sci Rep 2016;6:34605. [PMID: 27721459 DOI: 10.1038/srep34605] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 9.0] [Reference Citation Analysis]
125 Bao XY, Xu BB, Fang K, Li Y, Hu YH, Yu GP. Changing trends of hospitalisation of liver cirrhosis in Beijing, China. BMJ Open Gastroenterol 2015;2:e000051. [PMID: 26629359 DOI: 10.1136/bmjgast-2015-000051] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
126 Wang PX, Zhang XJ, Luo P, Jiang X, Zhang P, Guo J, Zhao GN, Zhu X, Zhang Y, Yang S, Li H. Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling. Nat Commun. 2016;7:10592. [PMID: 26882989 DOI: 10.1038/ncomms10592] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 11.7] [Reference Citation Analysis]
127 Yan FJ, Zhang XJ, Wang WX, Ji YX, Wang PX, Yang Y, Gong J, Shen LJ, Zhu XY, Huang Z, Li H. The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis. Hepatology. 2017;65:1492-1511. [PMID: 27981609 DOI: 10.1002/hep.28971] [Cited by in Crossref: 38] [Cited by in F6Publishing: 46] [Article Influence: 7.6] [Reference Citation Analysis]
128 Zhang X, Zhang JH, Chen XY, Hu QH, Wang MX, Jin R, Zhang QY, Wang W, Wang R, Kang LL, Li JS, Li M, Pan Y, Huang JJ, Kong LD. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation. Antioxid Redox Signal. 2015;22:848-870. [PMID: 25602171 DOI: 10.1089/ars.2014.5868] [Cited by in Crossref: 123] [Cited by in F6Publishing: 125] [Article Influence: 17.6] [Reference Citation Analysis]
129 Gong LL, Yang S, Zhang W, Han FF, Lv YL, Wan ZR, Liu H, Jia YJ, Xuan LL, Liu LH. Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy. J Pharmacol Sci 2018;136:189-95. [PMID: 29609842 DOI: 10.1016/j.jphs.2017.11.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
130 Jeong HS, Kim KH, Lee IS, Park JY, Kim Y, Kim KS, Jang HJ. Ginkgolide A ameliorates non-alcoholic fatty liver diseases on high fat diet mice. Biomed Pharmacother. 2017;88:625-634. [PMID: 28142119 DOI: 10.1016/j.biopha.2017.01.114] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
131 Liaqat M, Fatima M, Malik SS, Gillani SA, Manzoor I. Ultrasonographic Features Associated with Diffuse Hepatosteatosis among Diabetic Obese and Normal Body Mass Index Patients. J Med Ultrasound 2020;28:235-8. [PMID: 33659163 DOI: 10.4103/JMU.JMU_94_19] [Reference Citation Analysis]
132 Hinds TD Jr, Adeosun SO, Alamodi AA, Stec DE. Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor? Med Hypotheses 2016;95:54-7. [PMID: 27692168 DOI: 10.1016/j.mehy.2016.08.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
133 Hosseinabadi S, Rafraf M, Mahmoodzadeh A, Asghari-jafarabadi M, Asghari S. Effects of green coffee extract supplementation on glycemic indexes, leptin, and obesity values in patients with non-alcoholic fatty liver disease. Journal of Herbal Medicine 2020;22:100340. [DOI: 10.1016/j.hermed.2020.100340] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
134 Duncan AW, Hanlon Newell AE, Bi W, Finegold MJ, Olson SB, Beaudet AL, Grompe M. Aneuploidy as a mechanism for stress-induced liver adaptation. J Clin Invest. 2012;122:3307-3315. [PMID: 22863619 DOI: 10.1172/jci64026] [Cited by in Crossref: 117] [Cited by in F6Publishing: 78] [Article Influence: 11.7] [Reference Citation Analysis]
135 Wang ZQ, Zhang XH, Yu Y, Tipton RC, Raskin I, Ribnicky D, Johnson W, Cefalu WT. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway. Metabolism. 2013;62:1239-1249. [PMID: 23702383 DOI: 10.1016/j.metabol.2013.03.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
136 Veloso CD, Belew GD, Ferreira LL, Grilo LF, Jones JG, Portincasa P, Sardão VA, Oliveira PJ. A Mitochondrial Approach to Cardiovascular Risk and Disease. Curr Pharm Des 2019;25:3175-94. [PMID: 31470786 DOI: 10.2174/1389203720666190830163735] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
137 Sun X, Duan X, Wang C, Liu Z, Sun P, Huo X, Ma X, Sun H, Liu K, Meng Q. Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice. Eur J Pharmacol 2017;806:75-82. [PMID: 28414056 DOI: 10.1016/j.ejphar.2017.04.021] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
138 Li X, Gao P. Fatty liver increases gallstone disease risk in younger Chinese patients. Medicine (Baltimore) 2019;98:e15940. [PMID: 31145367 DOI: 10.1097/MD.0000000000015940] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
139 Crescenzo R, Bianco F, Mazzoli A, Giacco A, Liverini G, Iossa S. A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance. Eur J Nutr 2016;55:1-6. [PMID: 26476631 DOI: 10.1007/s00394-015-1073-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
140 Yang H, Tang L, Zhou X, Qian J, Zhu J, Lu L, Wang X. Ankaflavin ameliorates steatotic liver ischemia-reperfusion injury in mice. Hepatobiliary & Pancreatic Diseases International 2015;14:619-25. [DOI: 10.1016/s1499-3872(15)60361-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
141 Cartland SP, Harith HH, Genner SW, Dang L, Cogger VC, Vellozzi M, Di Bartolo BA, Thomas SR, Adams LA, Kavurma MM. Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice. Sci Rep. 2017;7:1898. [PMID: 28507343 DOI: 10.1038/s41598-017-01721-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
142 Terra X, Auguet T, Broch M, Sabench F, Hernández M, Pastor RM, Quesada IM, Luna A, Aguilar C, del Castillo D, Richart C. Retinol Binding Protein-4 Circulating Levels Were Higher in Nonalcoholic Fatty Liver Disease Vs. Histologically Normal Liver From Morbidly Obese Women. Obesity 2012. [DOI: 10.1038/oby.2012.114] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
143 Yilmaz Y. Review article: fructose in non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2012;35:1135-1144. [PMID: 22469071 DOI: 10.1111/j.1365-2036.2012.05080.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
144 Subasi CF, Aykut UE, Yilmaz Y. Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2015;27:137-141. [PMID: 25486027 DOI: 10.1097/meg.0000000000000255] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
145 Wu YC, Chuang PM, Pinotti R, Nagirimadugu A, Valentin N, Dinani A. The association of impaired lung function and nonalcoholic fatty liver disease: a systematic review. Eur J Gastroenterol Hepatol 2021;33:745-51. [PMID: 33394807 DOI: 10.1097/MEG.0000000000001967] [Reference Citation Analysis]
146 Kochan K, Kus E, Szafraniec E, Wislocka A, Chlopicki S, Baranska M. Changes induced by non-alcoholic fatty liver disease in liver sinusoidal endothelial cells and hepatocytes: spectroscopic imaging of single live cells at the subcellular level. Analyst 2017;142:3948-58. [PMID: 28944783 DOI: 10.1039/c7an00865a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
147 Zabala V, Tong M, Yu R, Ramirez T, Yalcin EB, Balbo S, Silbermann E, Deochand C, Nunez K, Hecht S. Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease. Alcohol Alcohol. 2015;50:118-131. [PMID: 25618784 DOI: 10.1093/alcalc/agu083] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
148 Chen H, Wang J, Li Z, Lam CWK, Xiao Y, Wu Q, Zhang W. Consumption of Sugar-Sweetened Beverages Has a Dose-Dependent Effect on the Risk of Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Dose-Response Meta-Analysis. Int J Environ Res Public Health 2019;16:E2192. [PMID: 31234281 DOI: 10.3390/ijerph16122192] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
149 Di Rosa M, Mangano K, De Gregorio C, Nicoletti F, Malaguarnera L. Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease. Hepatol Res. 2013;43:267-275. [PMID: 22971072 DOI: 10.1111/j.1872-034x.2012.01063.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
150 Shojaei Zarghani S, Abbaszadeh S, Alizadeh M, Rameshrad M, Garjani A, Soraya H. The Eeffect of Metformin Combined with Calcium-Vitamin D3 Against Diet-Induced Nonalcoholic Fatty Liver Disease. Adv Pharm Bull 2018;8:97-105. [PMID: 29670844 DOI: 10.15171/apb.2018.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
151 Matsuda S, Kobayashi M, Kitagishi Y. Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease. ISRN Endocrinol. 2013;2013:472432. [PMID: 23431468 DOI: 10.1155/2013/472432] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 8.1] [Reference Citation Analysis]
152 Pozzo L, Pucci L, Buonamici G, Giorgetti L, Maltinti M, Longo V. Effect of white wheat bread and white wheat bread added with bioactive compounds on hypercholesterolemic and steatotic mice fed a high-fat diet: White wheat bread and white wheat bread added on hypercholesterolemic and setatotic mice. J Sci Food Agric 2015;95:2454-61. [DOI: 10.1002/jsfa.6972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
153 Kim HM, Lee ES, Lee BR, Yadav D, Kim YM, Ko HJ, Park KS, Lee EY, Chung CH. C-C chemokine receptor 2 inhibitor ameliorates hepatic steatosis by improving ER stress and inflammation in a type 2 diabetic mouse model. PLoS One 2015;10:e0120711. [PMID: 25816097 DOI: 10.1371/journal.pone.0120711] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
154 Imai Y, Boyle S, Varela GM, Caron E, Yin X, Dhir R, Dhir R, Graham MJ, Ahima RS. Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression. Physiol Genomics 2012;44:1125-31. [PMID: 23012396 DOI: 10.1152/physiolgenomics.00045.2012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
155 Cartland SP, Tamer N, Patil MS, Di Bartolo BA, Kavurma MM. A "Western Diet" promotes symptoms of hepatic steatosis in spontaneously hypertensive rats. Int J Exp Pathol 2020;101:152-61. [PMID: 32783310 DOI: 10.1111/iep.12369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
156 Zhang H, Shen WJ, Li Y, Bittner A, Bittner S, Tabassum J, Cortez YF, Kraemer FB, Azhar S. Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats. Nutr Metab (Lond) 2016;13:63. [PMID: 27708683 DOI: 10.1186/s12986-016-0121-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
157 Irie M, Sohda T, Iwata K, Kunimoto H, Fukunaga A, Kuno S, Yotsumoto K, Sakurai K, Iwashita H, Hirano G. Levels of the oxidative stress marker γ-glutamyltranspeptidase at different stages of nonalcoholic fatty liver disease. J Int Med Res. 2012;40:924-933. [PMID: 22906265 DOI: 10.1177/147323001204000311] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
158 Kim E, Choi Y, Jang J, Park T. Carvacrol Protects against Hepatic Steatosis in Mice Fed a High-Fat Diet by Enhancing SIRT1-AMPK Signaling. Evid Based Complement Alternat Med 2013;2013:290104. [PMID: 23533470 DOI: 10.1155/2013/290104] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
159 Hu Y, Yin F, Liu Z, Xie H, Xu Y, Zhou D, Zhu B. Acerola polysaccharides ameliorate high-fat diet-induced non-alcoholic fatty liver disease through reduction of lipogenesis and improvement of mitochondrial functions in mice. Food Funct 2020;11:1037-48. [PMID: 31819934 DOI: 10.1039/c9fo01611b] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
160 Sellmann C, Jin CJ, Degen C, De Bandt J, Bergheim I. Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis. The Journal of Nutrition 2015;145:2280-6. [DOI: 10.3945/jn.115.215517] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
161 Xiong Q, Wu Y, Yang M, Wu G, Wang Y, Wang H, Feng J, Song L, Tong B, He G, Xu Y. Nr2e1 ablation impairs liver glucolipid metabolism and induces inflammation, high-fat diets amplify the damage. Biomedicine & Pharmacotherapy 2019;120:109503. [DOI: 10.1016/j.biopha.2019.109503] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
162 Imai N, Suzuki M, Hayashi K, Ishigami M, Hirooka Y, Abe T, Shioi G, Goto H, Fujimoto T. Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat Diet. PLoS One 2015;10:e0127114. [PMID: 25970332 DOI: 10.1371/journal.pone.0127114] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
163 Ghapanchi J, Zahed M, Haghnegahdar A, Niakan N, Sadeghzadeh A. Osteoporosis and Jaw Abnormalities in Panoramic Radiography of Chronic Liver Failure Patients. Biomed Res Int 2018;2018:4280312. [PMID: 30225253 DOI: 10.1155/2018/4280312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Liu X, Peng Y, Chen S, Sun Q. An observational study on the association between major dietary patterns and non-alcoholic fatty liver disease in Chinese adolescents. Medicine (Baltimore) 2018;97:e0576. [PMID: 29703050 DOI: 10.1097/MD.0000000000010576] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
165 Tzeng T, Lu H, Liou S, Chang CJ, Liu I. Cassia tora (Leguminosae) seed extract alleviates high-fat diet-induced nonalcoholic fatty liver. Food and Chemical Toxicology 2013;51:194-201. [DOI: 10.1016/j.fct.2012.09.024] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
166 Sharma A. Lipid droplets associated perilipins protein insights into finding a therapeutic target approach to cure non-alcoholic fatty liver disease (NAFLD). Futur J Pharm Sci 2022;8. [DOI: 10.1186/s43094-021-00395-0] [Reference Citation Analysis]
167 Üstüner MC, Tanrikut C, Üstüner D, Kolaç UK, Köroğlu ZÖ, Burukoğlu D, Entok E. The effect of baicalein on endoplasmic reticulum stress and autophagy on liver damage. Hum Exp Toxicol 2021;:9603271211003634. [PMID: 33779329 DOI: 10.1177/09603271211003634] [Reference Citation Analysis]
168 Kim HM, Lee BR, Lee ES, Kwon MH, Huh JH, Kwon BE, Park EK, Chang SY, Kweon MN, Kim PH, Ko HJ, Chung CH. iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner. Int J Obes (Lond) 2018;42:270-9. [PMID: 28811651 DOI: 10.1038/ijo.2017.200] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
169 Kishida K, Funahashi T, Shimomura I. Adiponectin as a routine clinical biomarker. Best Pract Res Clin Endocrinol Metab. 2014;28:119-130. [PMID: 24417951 DOI: 10.1016/j.beem.2013.08.006] [Cited by in Crossref: 89] [Cited by in F6Publishing: 90] [Article Influence: 9.9] [Reference Citation Analysis]
170 Ghaeni Pasavei A, Mohebbati R, Jalili-Nik M, Mollazadeh H, Ghorbani A, Nosrati Tirkani A, Taraz Jamshidi S, Hashemy SI, Heidarian Miri H, Soukhtanloo M. Effects of Rhus coriaria L. hydroalcoholic extract on the lipid and antioxidant profile in high fat diet-induced hepatic steatosis in rats. Drug Chem Toxicol 2021;44:75-83. [PMID: 33319629 DOI: 10.1080/01480545.2018.1533024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
171 Estrada-Meza J, Videlo J, Bron C, Saint-Béat C, Silva M, Duboeuf F, Peyruchaud O, Rajas F, Mithieux G, Gautier-Stein A. Tamoxifen Treatment in the Neonatal Period Affects Glucose Homeostasis in Adult Mice in a Sex-Dependent Manner. Endocrinology 2021;162:bqab098. [PMID: 33999998 DOI: 10.1210/endocr/bqab098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
172 Lee JS, Jun DW, Kim EK, Jeon HJ, Nam HH, Saeed WK. Histologic and Metabolic Derangement in High-Fat, High-Fructose, and Combination Diet Animal Models. ScientificWorldJournal 2015;2015:306326. [PMID: 26090514 DOI: 10.1155/2015/306326] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
173 Kishino Y, Tanaka Y, Ikeda T, Yamamoto K, Ogawa H, Iwatani Y, Kamisako T. Ezetimibe increases hepatic iron levels in mice fed a high-fat diet. J Pharmacol Exp Ther 2013;345:483-91. [PMID: 23538201 DOI: 10.1124/jpet.113.203448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
174 Zhang X, Wang Y, Liu P. Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease. Protein Cell 2017;8:4-13. [PMID: 27757845 DOI: 10.1007/s13238-016-0327-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
175 Padda J, Khalid K, Khedr A, Tasnim F, Al-Ewaidat OA, Cooper AC, Jean-Charles G. Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus. Cureus 2021;13:e17321. [PMID: 34557367 DOI: 10.7759/cureus.17321] [Reference Citation Analysis]
176 Carrión S, Torres L, Castañer O. Cardiovascular risk protection from the Mediterranean diet and olive oil. A transcriptomic update in humans. Grasas y Aceites 2016;67:161. [DOI: 10.3989/gya.0451161] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
177 Shan X, Miao Y, Fan R, Song C, Wu G, Wan Z, Zhu J, Sun G, Zha W, Mu X. Suppression of Grb2 expression improved hepatic steatosis, oxidative stress, and apoptosis induced by palmitic acid in vitro partly through insulin signaling alteration. In Vitro Cell Dev Biol Anim. 2013;49:576-582. [PMID: 23771793 DOI: 10.1007/s11626-013-9646-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
178 Zhu PL, Pan SY, Zhou SF, Zhang Y, Wang XY, Sun N, Chu ZS, Yu ZL, Ko KM. Effects of combined dietary supplementation with fenofibrate and Schisandrae Fructus pulp on lipid and glucose levels and liver function in normal and hypercholesterolemic mice. Drug Des Devel Ther 2015;9:923-35. [PMID: 25733812 DOI: 10.2147/DDDT.S73544] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
179 Sherriff JL, O'Sullivan TA, Properzi C, Oddo JL, Adams LA. Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes. Adv Nutr. 2016;7:5-13. [PMID: 26773011 DOI: 10.3945/an.114.007955] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 12.3] [Reference Citation Analysis]